These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2297 related items for PubMed ID: 8290310

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Genetically marking human cells--results of the first clinical gene transfer studies.
    Cai Q, Rubin JT, Lotze MT.
    Cancer Gene Ther; 1995 Jun; 2(2):125-36. PubMed ID: 7621260
    [Abstract] [Full Text] [Related]

  • 6. Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells.
    Berenstein M, Adris S, Ledda F, Wolfmann C, Medina J, Bravo A, Mordoh J, Chernajovsky Y, Podhajcer OL.
    Cancer Gene Ther; 1999 Jun; 6(4):358-66. PubMed ID: 10419054
    [Abstract] [Full Text] [Related]

  • 7. [Gene therapy--vectors and strategies].
    Huminiecki L.
    Postepy Biochem; 1995 Jun; 41(4):230-6. PubMed ID: 8851139
    [No Abstract] [Full Text] [Related]

  • 8. Intraarterial delivery of genetic vectors for the treatment of malignant brain tumors.
    Cohen ZR, Duvdevani R, Nass D, Hadani M, Ram Z.
    Isr Med Assoc J; 2001 Feb; 3(2):117-20. PubMed ID: 11344821
    [Abstract] [Full Text] [Related]

  • 9. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
    Rainov NG, Kramm CM, Aboody-Guterman K, Chase M, Ueki K, Louis DN, Harsh GR, Chiocca A, Breakefield XO.
    Cancer Gene Ther; 1996 Feb; 3(2):99-106. PubMed ID: 8729908
    [Abstract] [Full Text] [Related]

  • 10. Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.
    Uchibori R, Okada T, Ito T, Urabe M, Mizukami H, Kume A, Ozawa K.
    J Gene Med; 2009 May; 11(5):373-81. PubMed ID: 19274675
    [Abstract] [Full Text] [Related]

  • 11. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K.
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Retroviral vectors for gene therapy of AIDS and cancer.
    Chang LJ, He J.
    Curr Opin Mol Ther; 2001 Oct; 3(5):468-75. PubMed ID: 11699891
    [Abstract] [Full Text] [Related]

  • 16. Somatic gene therapy. Present situation and future perspective.
    Gottschalk U, Chan S.
    Arzneimittelforschung; 1998 Nov; 48(11):1111-20. PubMed ID: 9850435
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Human somatic cell gene therapy.
    Bank A.
    Bioessays; 1996 Dec; 18(12):999-1007. PubMed ID: 8976157
    [Abstract] [Full Text] [Related]

  • 19. Gene therapy for malignant neoplasms of the CNS.
    Culver KW.
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S6-9. PubMed ID: 8971399
    [Abstract] [Full Text] [Related]

  • 20. The current status of gene therapy in autologous transplantation.
    Becker PS.
    Acta Haematol; 2005 Dec; 114(4):188-97. PubMed ID: 16269858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 115.